- Home
- SGBX vs LIPO Comparison
SGBX vs LIPO Comparison
Compare SGBX & LIPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGBX
- LIPO
- Stock Information
- Founded
- SGBX 2007
- LIPO 2005
- Country
- SGBX United States
- LIPO United States
- Employees
- SGBX N/A
- LIPO N/A
- Industry
- SGBX RETAIL: Building Materials
- LIPO Biotechnology: Pharmaceutical Preparations
- Sector
- SGBX Consumer Discretionary
- LIPO Health Care
- Exchange
- SGBX Nasdaq
- LIPO Nasdaq
- Market Cap
- SGBX 2.7M
- LIPO 3.1M
- IPO Year
- SGBX 2017
- LIPO 2022
- Fundamental
- Price
- SGBX $0.81
- LIPO $2.99
- Analyst Decision
- SGBX
- LIPO
- Analyst Count
- SGBX 0
- LIPO 0
- Target Price
- SGBX N/A
- LIPO N/A
- AVG Volume (30 Days)
- SGBX 11.2M
- LIPO 39.2K
- Earning Date
- SGBX 06-17-2025
- LIPO 05-14-2025
- Dividend Yield
- SGBX N/A
- LIPO N/A
- EPS Growth
- SGBX N/A
- LIPO N/A
- EPS
- SGBX N/A
- LIPO N/A
- Revenue
- SGBX $4,976,618.00
- LIPO $519,866.00
- Revenue This Year
- SGBX $1,628.82
- LIPO N/A
- Revenue Next Year
- SGBX N/A
- LIPO N/A
- P/E Ratio
- SGBX N/A
- LIPO N/A
- Revenue Growth
- SGBX N/A
- LIPO 8.88
- 52 Week Low
- SGBX $0.30
- LIPO $1.97
- 52 Week High
- SGBX $3.75
- LIPO $12.00
- Technical
- Relative Strength Index (RSI)
- SGBX 51.99
- LIPO 58.50
- Support Level
- SGBX $0.40
- LIPO $2.75
- Resistance Level
- SGBX $1.50
- LIPO $3.17
- Average True Range (ATR)
- SGBX 0.23
- LIPO 0.29
- MACD
- SGBX 0.02
- LIPO 0.02
- Stochastic Oscillator
- SGBX 37.04
- LIPO 81.05
About SGBX Safe & Green Holdings Corp.
Safe & Green Holdings Corp is a modular solutions company. The company currently provides modules made out of both code-engineered cargo shipping containers and wood for use as both permanent or temporary structures for residential housing use and commercial use, including for health care facilities. It operates in four segments: construction services; medical; real estate development; and environmental. The company generates the majority of its revenue from the Construction segment includes the company's manufacturing unit SG ECHO and other modules projects.
About LIPO Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.